Pralatrexate is used to treat a certain type of cancer known as Peripheral T-Cell Lymphoma. It is an anti-cancer therapy.Reference standards of Pralatrexate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Pralatrexate
Catalogue No.:PA 16 2620000
CAS :
Molecular Formula : C23H23N7O5
Molecular Weight : 477.48
4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic Acid
Catalogue No.:PA 16 2621000
Molecular Formula : C18H16N6O2
Molecular Weight : 348.37
10-Propargyl-10-deazaminopterin Diethyl Ester
Catalogue No.:PA 16 2621001
Molecular Formula : C27H31N7O5
Molecular Weight : 533.59
Diethyl D-Glutamate Hydrochloride
Catalogue No.:PA 16 2621002
Molecular Formula : C9H18ClNO4
Molecular Weight : 239.7
(4-(2-(2,4-Diaminopteridin-7-yl)ethyl)benzoyl)glutamic Acid
Catalogue No.:PA 16 2621003
Molecular Formula : C20H21N7O5
Molecular Weight : 439.43
(2S)-2-(4-(1-(2-Amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic Acid
Catalogue No.:PA 16 2621004
Molecular Formula : C23H22N6O6
Molecular Weight : 478.47
10-Carbomethoxy Pralatrexate
Catalogue No.:PA 16 2621005
Molecular Formula : C25H25N7O7
Molecular Weight : 535.52
(4-(2-((2,4-Diaminopteridin-6-yl)methyl)-1-(2-methoxyethoxy)-1-oxopent-4-yn-2-yl)benzoyl)-L-glutamic Acid
Catalogue No.:PA 16 2621006
Molecular Formula : C27H29N7O8
Molecular Weight : 579.57
(4S)-4-(4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic Acid
Catalogue No.:PA 16 2621007
Molecular Formula : C24H25N7O5
Molecular Weight : 491.51
(2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic acid
Catalogue No.:PA 16 2621008
Dimethyl (4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamate
Catalogue No.:PA 16 2621009
Molecular Formula : C25H27N7O5
Molecular Weight : 505.54
(4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-D-glutamic Acid
Catalogue No.:PA 16 2621010
R-Pralatrexate
Catalogue No.:PA 16 2621011
Methyl 4-(1-methoxy-1-oxopent-4-yn-2-yl)benzoate
Catalogue No.:PAI 16 262001
Molecular Formula : C14H14O4
Molecular Weight : 246.26
Methyl 4-(2-((2,4-diaminopteridin-6-yl)methyl)-1-methoxy-1-oxopent-4-yn-2-yl)benzoate
Catalogue No.:PAI 16 262002
Molecular Formula : C21H20N6O4
Molecular Weight : 420.43
4-(2-Carboxy-1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic Acid
Catalogue No.:PAI 16 262003
Molecular Formula : C19H16N6O4
Molecular Weight : 392.38
1-(tert-Butyl) 5-methyl (4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamate
Catalogue No.:PAI 16 262004
Molecular Formula : C28H33N7O5
Molecular Weight : 547.62
S-Pralatrexate
Catalogue No.:PA 16 2621012
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
